Jiewen Zhu, Longen Zhou, Guikai Wu, Heiko Konig, Xiaoqin Lin, Guideng Li, Xiao-Long Qiu, Chi-Fen Chen, Chun-Mei Hu, Erin Goldblatt, Ravi Bhatia, A. Richard Chamberlin, Phang-Lang Chen and Wen-Hwa Lee A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia EMBO Molecular Medicine 5
Version of Record online: 22 JAN 2013 | DOI: 10.1002/emmm.201201760
A newly identified RAD51 inhibitor leading to degradation of RAD51 via the proteasome pathway inhibits cancer cell survival and greatly increases life spans in a mouse chronic myeloid leukaemia model.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field